BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34068084)

  • 1. The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice.
    Stucci LS; Internò V; Tucci M; Perrone M; Mannavola F; Palmirotta R; Porta C
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34068084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
    Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
    BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
    Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
    Savva C; De Souza K; Ali R; Rakha EA; Green AR; Madhusudan S
    Breast Cancer Res Treat; 2019 May; 175(1):105-115. PubMed ID: 30746633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
    Hallajian Z; Mahjoubi F; Nafissi N
    Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Karamat U; Ejaz S; Hameed Y
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):263-275. PubMed ID: 33877897
    [No Abstract]   [Full Text] [Related]  

  • 7. ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas.
    Bueno RC; Canevari RA; Villacis RA; Domingues MA; Caldeira JR; Rocha RM; Drigo SA; Rogatto SR
    Ann Oncol; 2014 Jan; 25(1):69-75. PubMed ID: 24285016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects.
    Iannuzzi CM; Atencio DP; Green S; Stock RG; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):606-13. PubMed ID: 11849780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
    Marabelli M; Cheng SC; Parmigiani G
    Genet Epidemiol; 2016 Jul; 40(5):425-31. PubMed ID: 27112364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ataxia-telangiectasia gene (
    Jerzak KJ; Mancuso T; Eisen A
    Curr Oncol; 2018 Apr; 25(2):e176-e180. PubMed ID: 29719442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
    Weigelt B; Bi R; Kumar R; Blecua P; Mandelker DL; Geyer FC; Pareja F; James PA; ; Couch FJ; Eccles DM; Blows F; Pharoah P; Li A; Selenica P; Lim RS; Jayakumaran G; Waddell N; Shen R; Norton L; Wen HY; Powell SN; Riaz N; Robson ME; Reis-Filho JS; Chenevix-Trench G
    J Natl Cancer Inst; 2018 Sep; 110(9):1030-1034. PubMed ID: 29506079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
    Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
    Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
    Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
    J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications.
    Bhattacharya N; Mukherjee N; Singh RK; Sinha S; Alam N; Roy A; Roychoudhury S; Panda CK
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S424-32. PubMed ID: 23117476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer.
    Suh KJ; Ryu HS; Lee KH; Kim H; Min A; Kim TY; Yang Y; Moon HG; Han SW; Oh DY; Han W; Park IA; Noh DY; Im SA
    Breast Cancer Res Treat; 2016 Jul; 158(2):233-41. PubMed ID: 27329169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
    Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B
    BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
    van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
    Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe reaction to radiotherapy provoked by hypomorphic germline mutations in ATM (ataxia-telangiectasia mutated gene).
    Asadollahi R; Britschgi C; Joset P; Oneda B; Schindler D; Meier UR; Rauch A
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1409. PubMed ID: 32748564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
    Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
    Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
    Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.